CSIMarket
 


Atara Biotherapeutics, Inc.  (ATRA)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

ATRA's Net Income Growth by Quarter and Year

Atara Biotherapeutics,'s Net Income results by quarter and year




ATRA Net Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December - -80.01 -35.31 -18.24
III Quarter September - -58.36 -31.10 -25.37
II Quarter June -74.33 -50.88 -27.43 -18.88
I Quarter March -66.26 -41.44 -25.65 -16.56
FY   -140.59 -230.69 -119.49 -79.05



ATRA Net Income second quarter 2019 Y/Y Growth Comment
Atara Biotherapeutics, Inc. in the second quarter recorded net loss of $ -74.33 millions.

According to the results reported in the second quarter, Atara Biotherapeutics, Inc. achieved the best Net Income growth in Biotechnology & Drugs industry. While Atara Biotherapeutics, Inc.' s Net Income no change of % ranks overall at the positon no. in the second quarter.




ATRA Net Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atara Biotherapeutics,'s second quarter 2019 Net Income $ -74.33 millions ATRA's Income Statement
Atara Biotherapeutics,'s second quarter 2018 Net Income $ -50.88 millions Quarterly ATRA's Income Statement
New: More ATRA's historic Net Income Growth >>


ATRA Net Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Net Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Income second quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Atara Biotherapeutics,'s Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q Net Income Comment
II. Quarter 2019 net loss of -74.33 millions by Atara Biotherapeutics, Inc. appear even worse if you take a look at -66.26 millions a quarter before.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Net Income growth. While Atara Biotherapeutics,'s Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ATRA's II. Quarter Q/Q Net Income Comment
Recent results of -74.33 millions by Atara Biotherapeutics, Inc. come out even less good compare to the -66.26 millions in the first quarter.

Within Biotechnology & Drugs industry Atara Biotherapeutics, Inc. achieved highest sequential Net Income growth. While Atara Biotherapeutics,'s Net Income growth quarter on quarter, overall rank is .


Atara Biotherapeutics,'s 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
12 Months Ending
12 Months Ending
12 Months Ending
Cumulative Net Income 12 Months Ending $ -278.96 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Net Income Growth (TTM) - - - - -
Year on Year Net Income Growth Overall Ranking # # # # #
Seqeuential Net Income Change (TTM) - - - - -
Seq. Net Income Growth (TTM) Overall Ranking # # # # #




Cumulative Net Income growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months net loss of $ -279 millions in the Jun 30 2019 period.
The results are detiriorating as the cumulative net loss is becoming larger from $ -255.51 millions in TTM ending quarter and $ -66.26 millions from the TTM period ending .

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Income growth Comment
Atara Biotherapeutics, Inc.' has realized cumulative trailing twelve months net loss of $ -279 millions in the Jun 30 2019 period.
The results are worsening as the cumulative net loss is becoming larger from $ -255.51 millions in the twelve months ending a quarter before and $ -66.26 millions from the TTM period ending .

Atara Biotherapeutics, Inc. achieved highest trailing twelve month year on year Net Income growth. While overall Net Income growth ranking, remained unchanged compare to the previous quarter at no. .

Net Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Net Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Income Growth
Biotechnology & Drugs Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ATRA's Net Income Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ATRA's Competitors
Net Income Growth for Atara Biotherapeutics,'s Suppliers
Net Income Growth for ATRA's Customers

You may also want to know
ATRA's Annual Growth Rates ATRA's Profitability Ratios ATRA's Asset Turnover Ratio ATRA's Dividend Growth
ATRA's Roe ATRA's Valuation Ratios ATRA's Financial Strength Ratios ATRA's Dividend Payout Ratio
ATRA's Roa ATRA's Inventory Turnover Ratio ATRA's Growth Rates ATRA's Dividend Comparisons



Companies with similar Net Income no change for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %Net Income for the quarter ending Jun 30 2019
Semler Scientific, Inc.  80.25 %$ 80.248 millions
Medpace Holdings, Inc.  65.71 %$ 65.711 millions
Biogen Inc.  63.29 %$ 63.290 millions
Galmed Pharmaceuticals Ltd.  55.27 %$ 55.270 millions
Iradimed Corp  54.16 %$ 54.162 millions
Merck & Co., Inc.  54.08 %$ 54.079 millions
Celgene Corp  50.33 %$ 50.335 millions
Biospecifics Technologies Corp  49.43 %$ 49.429 millions
Lhc Group, Inc  44.94 %$ 44.936 millions
Align Technology Inc  38.68 %$ 38.676 millions
Abbott Laboratories  37.24 %$ 37.244 millions
Apollo Medical Holdings, Inc.  35.58 %$ 35.577 millions
Lifevantage Corp  30.58 %$ 30.582 millions
Nuvasive Inc  29.75 %$ 29.755 millions
Vertex Pharmaceuticals Inc  29.66 %$ 29.662 millions
Ensign Group, Inc  29.56 %$ 29.557 millions
Addus Homecare Corp  28.42 %$ 28.415 millions
Icon Plc  28.31 %$ 28.312 millions
Intuitive Surgical Inc  24.27 %$ 24.273 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PEYE's Profile

Stock Price

PEYE's Financials

Business Description

Fundamentals

Charts & Quotes

PEYE's News

Suppliers

PEYE's Competitors

Customers & Markets

Economic Indicators

PEYE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071